Global Face Transplants Market, By Product (Lasers, Injectable, Implants, Microdermabrators, Others), Anatomical Structure (Scalp, Forehead, Eyelids, Cheeks, Chin, Nose, Lips, Ear, Neck, Lacrimal Glands, Salivary Glands, Tongue), Tissue Type (Bones, Cartilage, Tendons, Ligaments, Muscles, Nerves, Blood Vessels, Skin) – Industry Trends and Forecast to 2029.
Face Transplants Market Analysis and Size
The face transplants market is expected to witness significant growth during the forecast period. Face transplants have drawn much interest from both the medical community and the general public. FAT has advanced the fields of transplantation, immunology, and reconstructive microsurgery and cemented its position at the interdisciplinary intersection of other fields. Patients and doctors are required to handle various and occasionally enduring challenges, like managing immunosuppression and overcoming psychosocial barriers.
Data Bridge Market Research analyses a growth rate in the face transplants market in the forecast period 2022-2029. The face transplants market is tend to have a healthy CAGR in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Face Transplants Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Lasers, Injectable, Implants, Microdermabrators, Others), Anatomical Structure (Scalp, Forehead, Eyelids, Cheeks, Chin, Nose, Lips, Ear, Neck, Lacrimal Glands, Salivary Glands, Tongue), Tissue Type (Bones, Cartilage, Tendons, Ligaments, Muscles, Nerves, Blood Vessels, Skin)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Cutera (U.S.), Aetna Inc. (U.S.), ALLERGAN (U.S.), Mayo Foundation for Medical Education and Research (MFMER) (U.S.), The Johns Hopkins Health System Corporation (U.S.), Illumina, Inc. (U.S.), Cytori Therapeutics Inc. (U.S.), AbbVie Inc. (U.S.), Arthrex, Inc. (U.S.), Medtronic (Ireland), Novartis AG (Switzerland), Stryker (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Veloxis Pharmaceuticals, Inc. (U.S.), Zimmer Biomet (U.S.), Dr. Franz Köhler Chemie GmbH (Germany), Organogenesis Inc. (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
A face transplant is a medical surgery that uses tissue from a donor to replace overall or part of a person's face. It is a branch of medicine known as "vascularized composite tissue allotransplantation" (VCTA), which also includes the transplantation of facial skin, the bones that support the face, the nasal structure, the nose, the lips, the muscles that move the face to express oneself, the nerves that supply sensation, and possibly the facial bones. To suppress the immune system and prevent rejection, the face transplant recipient will require lifelong medication.
Face Transplants Market Dynamics
Drivers
- Improvement of surgical rates
On the other hand, the availability of qualified specialists and the improving surgical success rate will further enhance a number of prospects that will propel the face transplants market upward over the above-mentioned forecast period.
- Increasing transplant surgeries
The number of transplant surgeries, including those involving the kidney, liver, heart, lungs, and tissues, is anticipated to increase as transplantation technology improves and manufacturers introduce new goods. For instance, Lupin stated in November 2020 that the generic immunosuppressant medication tacrolimus would be available on the American market and be used to prevent organ rejection in allogeneic liver, kidney, and heart transplants.
Opportunities
- Rise in surgeries
Increased face transplant surgeries in developed economies, an increase in trauma injuries and accidents, and the introduction of cutting-edge technology that improves aesthetics are a few of the factors that are predicted to contribute to the face transplant market's expansion over the next years.
Restraints/Challenges
On the other hand, the rising cost of surgery along with psychological as well as ethical issues will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the face transplants market.
This face transplants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the face transplants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Face Transplants Market
The COVID-19 pandemic has rapidly evolved and changed our way of life in an unprecedented manner. Global face transplants have been altered by the emergence of COVID-19. Due to the severity of instances in some authorities exceeding capacity, the impact has not just been limited to concerns with donors or receivers but also the use of healthcare resources.
Global Face Transplants Market Scope
The face transplants market is segmented on the basis of product, anatomical structure and tissue type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Lasers
- Injectable
- Implants
- Microdermabrators
- Others
Anatomical Structure
- Scalp
- Forehead
- Eyelids
- Cheeks
- Chin
- Nose
- Lips
- Ear
- Neck
- Lacrimal Glands
- Salivary Glands
- Tongue
Tissue Type
- Bones
- Cartilage
- Tendons
- Ligaments
- Muscles
- Nerves
- Blood Vessels
- Skin
Face Transplants Market Regional Analysis/Insights
The face transplants market is analysed and market size insights and trends are provided by country, product, anatomical structure and tissue type as referenced above.
The countries covered in the face transplants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the face transplants market due to the prevalence of improved healthcare infrastructure along with rising healthcare expenditure by the population and large number of market players.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing healthcare expenditure along with rising medical tourism.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The face transplants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global face transplants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the face transplants market. The data is available for historic period 2010-2020.
Competitive Landscape and Face Transplants Market Share Analysis
The face transplants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to face transplants market.
Some of the major players operating in the face transplants market are:
- Cutera (U.S.)
- Aetna Inc. (U.S.)
- ALLERGAN (U.S.)
- Mayo Foundation for Medical Education and Research (MFMER) (U.S.)
- The Johns Hopkins Health System Corporation (U.S.)
- Illumina, Inc. (U.S.)
- Cytori Therapeutics Inc. (U.S.)
- AbbVie Inc. (U.S.)
- Arthrex, Inc. (U.S.)
- Medtronic (Ireland)
- Novartis AG (Switzerland)
- Stryker (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Veloxis Pharmaceuticals, Inc. (U.S.)
- Zimmer Biomet (U.S.)
- Dr. Franz Köhler Chemie GmbH (Germany)
- Organogenesis Inc. (Switzerland)
SKU-